May 03, 2018 09:30 am UTC| Business
Sacramento, CA, May 03, 2018 -- A new update has been published on Innovest Global, Inc. (OTC PINK: IVST). Innovest Global, Inc. is a diversified holding company that focuses on acquiring niche, high-growth businesses...
President of Innocap, Inc. is in Singapore
May 03, 2018 09:30 am UTC| Business
Jefferson, Texas, May 03, 2018 -- Mr. Tidwell, president of Innocap, Inc. (INNO), is traveling to Singapore on May 2 to advance the work on two salvage projects that are designed to recover large shipments of tin from...
Global Electric Vehicle (EV) Charging Station Market to witness a CAGR of 35.48% during 2018-2024
May 03, 2018 09:22 am UTC| Business
NEW YORK, May 03, 2018 -- The global electric vehicle charging station market is expected to witness a CAGR of 35.48% and is projected to reach 26.38 million units by 2024. The goal of introducing EV in the market is to...
Canadian Natural Resources Limited Announces Quarterly Dividend
May 03, 2018 09:05 am UTC| Business
CALGARY, Alberta, May 03, 2018 -- Canadian Natural Resources Limited announces its Board of Directors has declared a quarterly cash dividend on its common shares of C$0.335 (thirty-three and one half cents) per common...
May 03, 2018 09:05 am UTC| Business
IRVINE, Calif., May 03, 2018 -- Advantech, a leading global manufacturer of ruggedized embedded computing products, services and IoT (Internet of Things) solutions, and Timesys Corporation, industry pioneer and leading...
Affimed to Present at Deutsche Bank's 43rd Annual Health Care Conference
May 03, 2018 09:00 am UTC| Business
Heidelberg, Germany, May 3, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, announced today that Dr. Adi Hoess,...
Affimed Introduces ROCK(TM) Platform for Tailored Immune Cell Engagers
May 03, 2018 09:00 am UTC| Business
Redirected Optimized Cell Killing (ROCKTM) Platform Engages NK and T Cells to Activate Innate and Adaptive Immunity Heidelberg, Germany, May 3, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical...